Cs. Johnston et al., ANTIHISTAMINE EFFECT OF SUPPLEMENTAL ASCORBIC-ACID AND NEUTROPHIL CHEMOTAXIS, Journal of the American College of Nutrition, 11(2), 1992, pp. 172-176
Renewed interest in the antihistamine action of ascorbic acid has emer
ged with the recently recognized immunosuppressive role of histamine.
We examined the antihistamine effect of acute and chronic vitamin C (V
C) administration and its effect on neutrophil chemotaxis in healthy m
en and women. In the chronic study, 10 subjects ingested a placebo dur
ing weeks 1, 2, 5 and 6, and 2 g/day of VC during weeks 3 and 4. Fasti
ng blood samples were collected after the initial 2-week period (basel
ine) and at the end of weeks 4 and 6. Plasma ascorbate rose significan
tly following VC administration compared to baseline and withdrawal va
lues. Neutrophil chemotaxis rose 19% (NS) during VC administration, an
d fell 30% after VC withdrawal, but these changes were not correlated
to plasma ascorbate levels (r = 0.01). Chemotaxis was inversely correl
ated to blood histamine (r = -0.32, p = 0.045), and, compared to basel
ine and withdrawal values, histamine levels were depressed 38% followi
ng VC supplementation. Blood histamine and neutrophil chemotaxis did n
ot change 4 hours following a single 2 g dose of ascorbic acid, althou
gh plasma ascorbate rose 150%. These data indicate that VC may indirec
tly enhance chemotaxis by detoxifying histamine in vivo.